Recherche

On November 8, 2024, the Brussels University Hospital(H.U.B.) will host an international symposium dedicated to pediatric epilepsy neurosurgery. This event will bring together national and international experts to discuss the latest advancements and explore future perspectives in this highly specialized field Program and ThemesThe symposium will focus on several major themes aimed at improving the management of epileptic patients, particularly children resistant to medication. Topics to be covered include:Utilization of SEEG (Stereo-electroencephalography) and LITT (Laser Interstitial Thermal Therapy): These advanced techniques are crucial for pediatric patients whose epilepsy does not respond to traditional pharmaceutical treatments. SEEG provides a detailed analysis of brain activity to precisely locate epileptogenic zones, while LITT offers a minimally invasive method to treat these areas without resorting to traditional open surgery.Analysis of Neural Connectivity: This innovative method aims to predict the absence of postoperative seizures, allowing for more precise surgical planning and optimized outcomes for patients.New Surgical Approaches: The symposium will introduce a novel concept of proposing resective surgery for non-refractory focal epileptic children. The goal is to minimize the impact of antiepileptic drugs on children's cognitive development and quality of life by reducing the need for long-term pharmacological treatments.Experts and DiscussionsThe event will host renowned experts, both national and international, who will share their expertise, discuss the latest advancements, and explore future perspectives in pediatric epilepsy surgery.Registration and ProgramRegistrationProgramDate: November 8, 2024Time: 8:30 AM - 5:30 PMLocation: Musée de la Médecine, Erasme Hospital ULB, 808 route de Lennik, 1070 BrusselsContact Information: Email: Symposium_Epilepsy [dot] Neurosurgery [at] hubruxelles [dot] beFees:Medical Professionals: €60Paramedical Professionals and Students: €20

On June 19, 2024, Brussels University Hospital (H.U.B) invites you to a landmark event in honor of World Sickle Cell Day World Sickle Cell Day on June 19, 2024. Unveiling of the New Hospitalization Unit at Erasme. Join us as the Hematology Department at Erasme debuts its pioneering hospitalization unit designed exclusively for teenagers and adults with sickle cell disease. This milestone represents a significant leap forward in managing this intricate genetic disorder, providing a care environment meticulously tailored to meet the unique needs of its patients. Film and Testimonials Attendees will have the chance to view a documentary crafted specifically for this event, illuminating the daily challenges faced by those affected by sickle cell disease and their caregivers, alongside the latest promising therapeutic advancements. Encouraging Perspectives This event will also showcase the most recent developments in the treatment of sickle cell disease, focusing particularly on the exciting opportunities presented by gene therapy. This cutting-edge treatment modifies patients' cells to produce healthy hemoglobin. The narrative of the first patient treated with this method in Belgium will be shared. Understanding Sickle Cell Disease Sickle cell disease is a complex genetic condition that alters the properties of red blood cells and necessitates specialized, comprehensive care. The Erasme and HUDERF centers at H.U.B are renowned for their leadership in tackling this disease, providing state-of-the-art multidisciplinary care and actively driving research into innovative treatments. Registration Open Practical Information: Date and Time: June 19, 2024, beginning at 12 pm Location: Tagnon Auditorium, Jules Bordet Institute (H.U.B) Address: Rue Meylemeersch 90, 1070 Brussels The session will conclude with a networking luncheon. For further details, please contact us via email at secretariat [dot] hematologie [at] hubruxelles [dot] be (secretariat[dot]hematologie[at]hubruxelles[dot]be)

In the complex landscape of youth mental health, eating disorders (EDs) present significant challenges, requiring sustained attention and swift action. As June 2nd marks World Eating Disorders Action Day, raising awareness about the early detection and treatment of these devastating disorders is crucial What Are Eating Disorders? Eating disorders involve much more than just disturbed eating habits. They are psychiatric illnesses characterized by a dysfunctional relationship with food, weight, and body image. Predominantly observed in adolescents, these disorders can appear at any age and affect men as well. Anorexia nervosa, bulimia nervosa, and binge eating disorder are among the most common forms, with profound impacts on an individual's physical and mental health.Early DetectionThe vigilance of parents and healthcare professionals is essential in identifying the early signs of EDs. Any changes in eating habits, an obsession with weight and appearance, and signs of social withdrawal and low self-esteem must be taken seriously. Early detection can prevent severe complications and improve the chances of recovery.Family-Based Therapy (FBT)For those who suspect the presence of an ED in their child or adolescent, prompt medical consultation is imperative. At Erasme Hospital and the Children's Hospital, Silvana Fuso, a specialist in EDs, offers an innovative approach with Family-Based Therapy (FBT). This method actively involves parents in the therapeutic process, providing crucial familial support for recovery.Read our page dedicated to this health issueContact InformationTo schedule an appointment with Silvana Fuso:Erasme Hospital: EMC Child and Adolescent ConsultationSecretariat: +32 2 555 32 96Appointment Request FormChildren's Hospital (Huderf)University Children's Hospital's Child Psychiatry Service: +32 2 477 3180Appointment Request Form

Lien vers Doctors General practitioners and specialists Doctors Image Lien vers Nurses Paramedical sector Nurses Image

In November 2024, this specialty will be highlighted during a dedicated event, underscoring the importance and advancements of epilepsy neurosurgery in Belgium. Healthcare professionals will have the opportunity to gather, share their knowledge, and explore new perspectives offered by this discipline. Epilepsy neurosurgery in Belgium: a leading specializationIn Belgium, neurosurgery, and more specifically epilepsy neurosurgery, represents a medical specialty that is both advanced and rare. Essential for the treatment of patients with epilepsy who are refractory to traditional medication treatments, this discipline is distinguished by its cutting-edge techniques and promising results.State-of-the-art equipment at the H.U.B.The Brussel University Hospital (H.U.B.) stands out for its use of advanced technologies for the treatment of epilepsy, notably SEEG (stereo-electroencephalography) and, soon, LITT (laser interstitial thermotherapy). The H.U.B. boasts some of the leading specialists who utilize this advanced equipment, crucial for pediatric patients resistant to traditional pharmaceutical treatments.SEEG: precision and effectivenessSEEG provides a detailed mapping of brain activity, accurately pinpointing epileptogenic zones. With this technique, neurosurgeons can identify the areas responsible for epileptic seizures with great precision, facilitating more targeted and effective interventions.LITT: minimally invasive innovationSoon, the H.U.B. will integrate LITT into its treatment protocols. This technique offers a minimally invasive solution for treating the epileptogenic zones identified by SEEG, using a laser to destroy the brain tissue responsible for seizures. LITT serves as an effective alternative to traditional open surgeries when the functional or cognitive risk is too high. It provides a curative solution for patients who were previously deemed inoperable.An international symposium in November 2024On November 8, 2024, the H.U.B. will host an international symposium dedicated to epilepsy neurosurgery. This event will bring together world-renowned experts to discuss the latest advancements and innovative perspectives in this highly specialized field. The goal is to improve the care of epilepsy patients and to promote cutting-edge surgical techniques.Practical InformationDate: November 8, 2024Time: 8:30 AM - 5:30 PMLocation: Museum of Medicine, Erasme Hospital ULB, 808 route de Lennik, 1070 BrusselsTo access the detailed program and register, please follow this link.

On 25 October 2024 Brussels University Hospital will be celebrating 25 years of its Gamma Knife Centre. Image To mark the occasion, a scientific day in the presence of experts is being organised. Practical informationWhen? 25 October 2024 from 9 am to 5:30 pmWhere? The Royal Library of Belgium –Boulevard de l’Empereur,4 -1000 Brussels Program Click here Accreditation in ethics and economicsRegistration REGISTRATION

Title First name Last name National Security number File number Invoice number Phone number / mobile Email Number of monthly instalments / Amount Your motivation

JUNE 19, 2024 | 12:00 PM - 2:00 PM H.U.B is proud to support the SICKEL CELL DISEASE AWARNESS DAY On this occasion, we are pleased to present: The first unit for adolescent and adult hospitalization Videos and testimonials An overview of the latest innovations for this rare disease Join us on June 19 at 12:00 PM at Auditorium Tagnon The presentation will be followed by a luncheon cocktail Registration Open Date and Time: June 19, 2024, beginning at 12 pm Location: Tagnon Auditorium, Jules Bordet Institute (H.U.B) Address: Rue Meylemeersch 90, 1070 Brussels The session will conclude with a networking luncheon. For further details, please contact us via email at secretariat [dot] hematologie [at] hubruxelles [dot] be (secretariat[dot]hematologie[at]hubruxelles[dot]be)

Image Contact the Inflammatory Bowel Disease (IBD) Clinic. Would you like to make an appointment for a consultation with an IBD clinic specialist for yourself or for one of your relatives?Contact us by phone at +32 (0)2 555 35 04 or by email at: ibd [dot] erasme [at] hubruxelles [dot] beWould you like to make an appointment for an endoscopy with an IBD clinic specialist for yourself or for one of your relatives?Contact us by phone at +32 (0)2 555 3292 or by email at: ibd [dot] erasme [at] hubruxelles [dot] beAre you a patient and do you have an administrative request (prescriptions, reimbursements, certificates, insurance documents, or copies of medical records)?Contact our medical administration by phone at +32 (0)2 555 5422 or by email at: ibd [dot] erasme [at] hubruxelles [dot] beAre you a doctor and would you like to obtain medical results for your patients, refer a patient, or request a (second) opinion?Contact our clinic by phone at +32 (0)2 555 54 22 or by email at: ibd [dot] erasme [at] hubruxelles [dot] be Do you suffer from an Inflammatory Bowel Disease (IBD)? The Inflammatory Bowel Diseases (IBD) Clinic provides care for all patients with Crohn’s disease, ulcerative colitis, unclassified colitis, lymphocytic/collagenous colitis, as well as celiac disease and intestinal autoimmune diseases or vasculitis Image Image Image Comprehensive care Several specialized consultations are developed for the management of adolescents, pregnant or breastfeeding women, screening for primary immunodeficiency syndromes in adults, and patients with celiac disease or autoimmune enteritis. Multidisciplinary approach There is strong multidisciplinary collaboration in the care of patients with inflammatory bowel disease, particularly during a weekly meeting (“round table”) with colorectal surgeons, radiologists, pathologists, rheumatologists, and dermatologists (as well as ophthalmologists or other specialists involved in immunodeficiency-related conditions).  Discover the Inflammatory Bowel Disease (IBD) Clinic of Hôpital Erasme H.U.B. Image Prof. Denis Franchimont, Director of the Inflammatory Bowel Diseases Clinic SpecialtiesInflammatory bowel diseases.Colon cancer screening and genetic screening for hereditary colorectal cancer syndromes.Diagnostic and therapeutic gastroscopy and colonoscopy.Upper digestive and anorectal endoscopic ultrasound.Resection of superficial colorectal tumors.  Prendre rendez-vous avec le Prof. Franchimont A team of specialists by your side DoctorsProf. Claire LiefferinckxProf. Anneline CremerProf. Leila AmininejadDr. Cagla GulkilikDr. Clémence VukovicProf. Denis FranchimontClinical studies and trials coordinationCharlotte Minsart, PhD in Biomedical SciencesEmma DescampsChloé HelmanClinic coordinating nurseValérie WambacqDietitianPauline Van OuytselConsultantsDr. Vincent BouillonDr. Haydeh Vafa ZanjaniMedical secretaryGeorgiana Vilcinschi A clinic committed to research The clinic is actively involved in pharmaceutical clinical research (we have access to new molecules within international clinical trials), as well as translational and genetic research, particularly in collaboration with the BIRD (Belgium IBD Research Disease Group), the ECCO (European Crohn’s and Colitis Organisation), and the IIBDGC (International IBD Genetics Consortium)BIRD (Belgium IBD Research Disease Group), l’ECCO (European Crohn and Colitis Organisation) et le IIBDGC (International IBD Genetics Consortium).  In 2022, the clinic opened its translational research laboratory on the microbiota — the H.U.B Center for the Study of Inflammatory Bowel Disease (IBD) and Microbiota — where 3 physicians, a technician, two PhD students, and an artificial intelligence engineer work Our scientific publications In-depth study of monogenic primary immunodeficiency genes identifies rare XIAP variants in Crohn’s disease patients. Amininejad L, Charloteaux B, Theatre E, Dmitrieva J, Hayard P, Muls V, Maisin J-M, Schapira M, Ghislain J-M, Closset P, Talib M, Abramowicz M, Momozawa Y, Deffontaine V, Crins F, Mni M, Karim L, Cambisano N, Deviere J, Hugot J-P, De vos M, Louis E, Vermeire S, Van Gossum A, Coppieters W, Twizere J-C, Georges M, Franchimont D.  Gastroenterology 2018 Jun;154(8):2165-2177 (I.F. 33) 01 June 2018 Lien vers https://pubmed.ncbi.nlm.nih.gov/31202983/ Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia Cremer A, Demetter P, De Vos M, Rahier JF, Baert F, Moreels T, Macken E, Louis E, Ferdinande L, Fervaille C, Dedeurwaerdere F, Bletard N, Driessen A, De Hertogh G, Vermeire S, Franchimont D.  Clin Gastroenterol Hepatol. 2019 Jun 13. pii: S1542-3565(19)30645-7 13 June 2019 Lien vers https://www.researchgate.net/publication/350498118_Collecting_New_Peak_and_Inte… Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases Liefferinckx C, Bottieau J, Toubeau JF, Thomas D, Rahier JF, Louis E, Baert F, Dewint P, Pouillon L, Lambrecht G, Vallée F, Vermeire S, Bossuyt P, Franchimont D.  Inflamm Bowel Dis. 2022 Feb 1;28(2):208-217.  01 February 2022 Lien vers https://www.nature.com/articles/s41588-022-01156-2 Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility . Sazonovs A, Stevens CR, Venkataraman GR, Yuan K, Avila B, Abreu MT, Ahmad T, Allez M, Ananthakrishnan AN, Atzmon G, Baras A, Barrett JC, Barzilai N, Beaugerie L, Beecham A, Bernstein CN, Bitton A, Bokemeyer B, Chan A, Chung D, Cleynen I, Cosnes J, Cutler DJ, Daly A, Damas OM, Datta LW, Dawany N, Devoto M, Dodge S, Ellinghaus E, Fachal L, Farkkila M, Faubion W, Ferreira M, Franchimont D, Gabriel SB, Ge T, Georges M, Gettler K, Giri M, Glaser B, Goerg S, Goyette P, Graham D, Hämäläinen E, Haritunians T, Heap GA, Hiltunen M, Hoeppner M, Horowitz JE, Irving P, Iyer V, Jalas C, Kelsen J, Khalili H, Kirschner BS, Kontula K, Koskela JT, Kugathasan S, Kupcinskas J, Lamb CA, Laudes M, Lévesque C, Levine AP, Lewis JD, Liefferinckx C, Loescher BS, Louis E, Mansfield J, May S, McCauley JL, Mengesha E, Mni M, Moayyedi P, Moran CJ, Newberry RD, O'Charoen S, Okou DT, Oldenburg B, Ostrer H, Palotie A, Paquette J, Pekow J, Peter I, Pierik MJ, Ponsioen CY, Pontikos N, Prescott N, Pulver AE, Rahmouni S, Rice DL, Saavalainen P, Sands B, Sartor RB, Schiff ER, Schreiber S, Schumm LP, Segal AW, Seksik P, Shawky R, Sheikh SZ, Silverberg MS, Simmons A, Skeiceviciene J, Sokol H, Solomonson M, Somineni H, Sun D, Targan S, Turner D, Uhlig HH, van der Meulen AE, Vermeire S, Verstockt S, Voskuil MD, Winter HS, Young J; Belgium IBD Consortium; Cedars- Sinai IBD; International IBD Genetics Consortium; NIDDK IBD Genetics Consortium; NIHR IBD BioResource; Regeneron Genetics Center; SHARE Consortium; SPARC IBD Network; UK IBD Genetics Consortium; Duerr RH, Franke A, Brant SR, Cho J, Weersma RK, Parkes M, Xavier RJ, Rivas MA, Rioux JD, McGovern DPB, Huang H, Anderson CA, Daly MJ.  Nat Genet. 2022 Sep;54(9):1275-1283.  29 August 2022 Resources and Useful Links for Patients with Crohn’s Disease, Colitis, and Inflammatory Bowel Diseases (IBD) Whether you have already been diagnosed or suspect you may have an inflammatory bowel disease (IBD), we are here to support and guide you step by step. That is why we offer a series of content (produced by doctors, researchers, patient associations, and public health stakeholders) to help you better understand your disease, manage it, and identify support groups with which to connect. ASSOCIATION - L’association Crohn-RCUH asbl tente de répondre aux besoins socia… ASSOCIATION - Société Belgique de la Coeliaquie PODCAST - MICI Today Le podcast dédié aux affections inflammatoires du tube dig… FONDATION - BRIDGE - Brussels IBD Effort, a Network of ULB Hospitals FAQ on Crohn's disease and Colites 1. What is Crohn’s disease? Crohn’s disease is a chronic inflammatory bowel disease (IBD) that can affect any part of the digestive tract, from the mouth to the anus. It is characterized by segmental inflammation and can lead to complications such as strictures or fistulas. 2. 2. What are the differences between Crohn’s disease and other types of colitis? Crohn’s disease can affect the entire digestive tract, with discontinuous lesions.Ulcerative colitis (UC) affects only the colon and rectum, with continuous lesions.Infectious colitis is caused by bacteria, viruses, or parasites and is usually temporary.Ischemic colitis results from reduced blood flow to the colon.Microscopic colitis (lymphocytic and collagenous) is only visible under a microscope and causes chronic diarrhea. 3. What are the main symptoms of Crohn’s disease? Symptoms include abdominal pain, diarrhea (sometimes with blood), weight loss, fatigue, and sometimes fever. Extra-intestinal manifestations may also occur, such as joint pain, skin rashes, or eye problems. 4. Is Crohn’s disease hereditary? There is a genetic predisposition: about 10 to 20% of patients have a family member with an inflammatory bowel disease (IBD). However, environmental and immunological factors are also required for the disease to develop.  5. How is Crohn’s disease distinguished from infectious colitis? Infectious colitis is usually acute and caused by an identifiable infection (bacteria, viruses, parasites). Stool tests can confirm the infectious origin. Crohn’s disease, on the other hand, is chronic, with recurrent flare-ups and periods of remission. 6. What treatments are available for Crohn’s disease? Treatments include:Anti-inflammatory drugs (such as mesalazine or corticosteroids).Immunosuppressants (azathioprine, methotrexate).Biologic therapies targeting specific molecules (anti-TNF, anti-IL12/23, etc.).In case of complications, surgery may be required to remove affected segments of the intestine. 7. Can Crohn’s disease cause serious complications? Yes, it can lead to:Stenoses (narrowing of the intestine that may cause obstructions).Fistulas (abnormal connections between organs or with the skin).Abscesses.Increased risk of colorectal cancer (in cases of long-term inflammation). 8. Which factors worsen colitis and Crohn’s disease? Stress and anxiety can worsen symptoms.Smoking particularly aggravates Crohn’s disease.An unbalanced or irritating diet can intensify flare-ups. 9. Can diet prevent or cure colitis and Crohn’s disease? There is no diet that can cure the disease, but certain dietary choices may help relieve symptoms. Low-residue or low-FODMAP diets are often used during flare-ups. A balanced diet is essential to avoid deficiencies. 10. How do people live with a chronic disease like Crohn’s disease or colitis? With appropriate treatment, many patients can achieve remission and lead a normal life.Regular follow-up with a gastroenterologist is important.Participation in support groups or patient associations can help cope with the psychological impact of the disease. Supported by

Image The ZELIG CenterZELIG is an outpatient service designed for young people aged 12 to 21 living in the Brussels-Capital Region*, who are facing recent psychological and functional difficulties that have emerged within the past six months.The center’s mission is to identify early signs of psychological distress before they worsen. By ensuring timely access to care, ZELIG aims to prevent complications and the progression of mental health disorders.Our approach prioritizes swift responses to initial requests and thorough, systematic evaluations of each situation. We offer a tailored care pathway focused on addressing symptoms related to psychiatric conditions through early detection and relapse prevention.*An appropriate solution will be offered in the event of language or communication difficulties between the patient and the healthcare professional. If necessary, the patient may be referred to another specialised centre to ensure optimal understanding, which is essential for the quality and safety of care. We kindly ask you to contact us by email before making an appointment.%20%20zelig [dot] pij [at] hubruxelles [dot] be (Envoyer un message) Image The ZELIG ProjectThe program is built on evaluation, feedback, and targeted support. This support is structured around group workshops and individual follow-ups, both of which are therapeutic and psychoeducational in nature.At ZELIG, we ensure that every young person receives comprehensive and personalized support throughout their care journey.Initial information is gathered via phone or email. Following an analysis of the request, a consultation may be offered to conduct a deeper evaluation. After this preliminary meeting, a multidisciplinary team discussion is organized to determine the best course of action: either providing support at the center or referring the young person elsewhere. Evaluation scales may also be employed to enhance the assessment process.This approach is based on three key dimensions: individual, group-based, and network-focused. Individual follow-up allows for care tailored to the young person’s specific needs, while group sessions foster peer interaction and reduce isolation. Engaging key figures and external networks ensures continuity of care outside the center. Finally, psychoeducational sessions can also be offered to families and close contacts. Docteur Simone Marchini Lead Physician at ZELIGChild and Adolescent PsychiatristSpecialist in early detection and intervention for adolescents and young adultsDr. Marchini is pursuing a doctorate in science at the Faculty of Medicine, ULB. Her research focuses on developing a dimensional approach to psychiatric disorders in adolescents and young adults. Image An expert team by your side Dr. Simone Marchini: Child and Adolescent Psychiatrist, Medical DirectorDr. Edeline Clin: Child and Adolescent Psychiatrist in TrainingClinical Psychologist:Lina Regragui: Specializing in Cognitive Behavioral Therapy (CBT)Neuropsychologist: Ella Ben-ShaoolTwo Specialized Nurses:Natalia Polozova DelaitreDéborah MorchoisneSpecialized Educator: Steven Nicaise “Peer Support” Intern: A patient partner trained for two years through the Brussels Platform for Mental HealthPrendre Rendez-vous  Early Detection of Psychiatric DisordersEarly detection of psychiatric conditions is not solely the responsibility of the ZELIG Center. It also relies on the young person's daily network: parents, relatives, teachers, sports coaches, general practitioners, and others. These key figures are often the first to notice signs of distress and alert ZELIG, enabling prompt and effective intervention.Additionally, we work closely with mental health professionals already involved in the young person’s care. This collaboration ensures continuity and consistency in the support provided.Brochure ZELIG Partner Sites of ZELIGPlateforme Bruxelloise pour la Santé mentaleBru-Stars - Réseau Bruxellois en Santé Mentale pour les Enfants et AdolescentsSimiles - association pour les familles & amis Équipes liégeoises - EcoToneLe P.A.A.T.  (Pôle Ambulatoire - Age de Transition à Liège)Equipe de VRINT à LouvainEquipe mobile âge de transition à ANVERSUZ VUB à Jette  The Prodromal Questionnaire (QP-16)The QP-16 is a screening tool designed to identify young individuals who may require a more in-depth evaluation.Recommended UseThis questionnaire is intended for frontline professionals (general practitioners, psychologists, etc.) who encounter young people displaying concerning signs. They can ask the individual to complete the QP-16.Interpreting ResultsA score of 6 or more true items serves as a strong indicator to consider referring the individual to the ZELIG program.This tool supports the early detection of prodromal signs and facilitates appropriate intervention.The goal of this screening is to enable the early identification of young people in distress and promote rapid, targeted support.Questionnaire Prodromique FAQ What criteria do you use to refer a young person to your program? ZELIG is a program designed for young people aged 12 to 21 residing in the Brussels-Capital Region who are experiencing recent psychological and functional difficulties, emerging within the last six months. The goal of ZELIG is to detect the early signs of psychiatric disorders before they escalate.These signs may include, for instance, a recent withdrawal from daily life, behavioral changes, a distorted perception of reality (feeling of strangeness), the onset of psychological distress, a breakdown in peer relationships, or disturbances in sensory perceptions—such as hearing whispers, seeing objects move, or experiencing unusual bodily sensations.In some cases, these symptoms may signal the onset of an emerging psychiatric condition, requiring timely and tailored intervention. Who can refer a young person to us? Young people can make requests themselves, as can their parents and/or close contacts. Any professional can also reach out to us, provided the young person is informed and gives their consent. How can I request an evaluation? You can send us an email at ZELIG [dot] PIJ [at] hubruxelles [dot] be.We will respond as quickly as possible to gather the initial necessary information and, if appropriate, schedule an appointment. What steps are involved in the evaluation process? To ensure a prompt response, the process begins with an initial interview involving two team members. This is followed by a medical appointment with a child and adolescent psychiatrist. Additionally, other appointments may be scheduled for administering standardized assessment tools. Medical tests might also be prescribed to rule out any underlying physical conditions.At the end of this process, a feedback session is held with the involved team members to discuss the results and propose potential courses of action. What evaluation tools do you use? Our evaluations are comprehensive. They may include physical health assessments, semi-structured interviews, and standardized scales, all aimed at enriching and refining the care process. Are the services free of charge? The fees are regulated by INAMI rates. It is necessary to have valid health insurance coverage. Is there a similar program in the Flemish and Walloon regions? Walloon region(Liège) :Équipes liégeoises - EcoToneLe P.A.A.T.  (Pôle Ambulatoire - Age de Transition à Liège)Flemish Region:Equipe de VRINT à LOUVAINEquipe mobile âge de transition à ANVERS What should I do if my child or friend isolates themselves and no longer leaves their home? You can reach out to mobile teams. The appropriate mobile team to contact will depend on the young person’s age and place of residence.For example: Bru-Stars - Réseau Bruxellois en Santé Mentale pour les Enfants et Adolescents Does your center provide support for families? Yes, we offer family support. The "BREF" module (sessions focused on family psychoeducation) is an intervention designed for the caregivers of young people supported by the ZELIG program.For additional support, you can also reach out to caregiver associations:Similes - association pour les familles & amis Plateforme Bruxelloise pour la Santé mentale The evaluation… what happens next? The feedback from the assessments provides a range of tools that can benefit both the young person and their family or close contacts. Supported follow-up through individual sessions (medical, psychological, and case management) helps prevent or even avoid future deterioration.The tools include:Establishing a care network if none exists and if it is relevant for the young person.Psychoeducational and psychotherapeutic group workshops.Support for the young person’s family/close contacts (psychoeducation).Most importantly, reactivating the young person’s network to help them build a life project focused on personal growth, self-affirmation, maintaining and creating connections, and ultimately achieving self-realization.  +32(0)2 555 80 04  ZELIG.PIJ@hubruxelles.be Erasme Medical Center (EMC) Route de Lennik 900 − 1070 Bruxelles Standard +32 (0)2 555 31 11 Image

Image Are you a physician wishing to refer a patient or obtain the medical results of one of your patients? Please SecMed [dot] Cardio [dot] erasme [at] hubruxelles [dot] be (contact our medical secretariat). The Clinic where cutting-edge technology meets a human touch The Cardiovascular Prevention Clinic of the Brussels University Hospital is committed to promoting optimal cardiovascular health through a multidisciplinary and personalized approach. Image Image Image A comprehensive evaluation thanks to modern diagnostic tools Our mission is to prevent cardiovascular diseases by identifying the specific risk factors of each patient and offering tailored solutions. We combine specialized consultations, state-of-the-art diagnostic tools, and educational programs to encourage a healthy and sustainable lifestyle. A holistic approach for comprehensive care Our strengths rest on a dedicated team of experts, latest-generation technologies, and close collaboration between medical disciplines. We distinguish ourselves through a comprehensive approach to care that integrates not only medical follow-up, but also nutritional, physical, and psychological support. As a reference center, we place prevention at the very heart of our priorities, helping everyone reduce their risks and preserve their quality of life. Our Range of Care The Cardiovascular Prevention Clinic of the Brussels University Hospital offers a comprehensive and personalized range of care to reduce the risk of cardiovascular disease and improve quality of life.Each prevention program is tailor-made, taking into account the medical history, lifestyle, and specific needs of each patient. This individualized approach promotes better adherence to recommendations and helps establish sustainable lifestyle changes, effectively reducing long-term cardiovascular risks.Our services include:Risk assessment: A detailed evaluation of cardiovascular risk factors (hypertension, cholesterol, diabetes, smoking, etc.).Personalized advice: A prevention plan tailored to your profile, including nutrition, physical activity, and stress management.Specialized follow-up: Regular consultations with cardiologists and other specialists.Educational programs: Workshops to better understand and manage your cardiovascular health.Advanced technologies: State-of-the-art imaging and diagnostic tests for early detection.By combining advice on nutrition, physical activity, stress management, and health education, the clinic is committed to treating not only physical factors but also the emotional and psychological dimensions that influence cardiovascular health. This comprehensive support builds a true therapeutic alliance, boosting patient motivation and well-being. Focus on Sports Cardiology and Cardiovascular Rehabilitation Sports Cardiology is a discipline focused on prevention and medical follow-up for the cardiovascular health of active individuals, including both amateur and high-level athletes, as well as patients with a cardiovascular pathology.Cardiovascular rehabilitation, when combined with Sports Cardiology, helps improve the quality of life for patients who have experienced a cardiovascular medical or surgical event, aligning with their personal goals. It also plays an essential role in patient therapeutic education, encouraging them to take an active role in managing their condition. Contact us Prof. Philippe van de Borne, Director of the Cardiovascular Prevention Clinic Director of the Cardiology Department (Research and Education), Erasmus Hospital, ULB, Brussels, Belgium.Director of Cardiovascular Prevention and Rehabilitation, Erasmus Hospital, ULB, Brussels, Belgium.Professor of Cardiovascular Pathology, Faculty of Medicine and Faculty of Motor Sciences, ULB, Brussels, Belgium. Book an appointment with Prof. van de Borne Professor van de Borne conducts extensive research focusing on cardiovascular variability, arterial hypertension, and the interactions between sleep and the cardiovascular system. He has contributed to more than 250 scientific publications and is frequently cited in medical literature. He plays an active role in promoting cardiovascular health in Belgium.In 2023, he co-proposed the adoption of a national plan to combat cardiovascular diseases, emphasizing the importance of prevention and the tailored management of risk factors. Professor van de Borne is a member of the Advisory Board of the European Society of Hypertension, an ex-officio member of the Board of the European Society of Hypertension, and a scientific advisor to the French Society of Hypertension. He has previously served as a member of the "Hypertension and the Heart" working group of the European Society of Cardiology, president of the Belgian Hypertension Committee, and president of the Belgian Working Group on Cardiovascular Prevention and Rehabilitation.His dedication to education, research, and prevention makes him a central figure in the field of cardiovascular prevention in Belgium. Dr. Gabriela Flores Vivian, Interventional and Sports Cardiologist Dr. Flores Vivian is a cardiologist with over 20 years of experience. She played a key role in the inception of interventional cardiology in Mons in 2016. Trained in Interventional Cardiology, she is deeply committed to preventive cardiology and is a member of the European Association of Preventive Cardiology (EAPC). She completed her training in Sports Cardiology at Sorbonne University in Paris and has practiced at the Sports Medicine Center in collaboration with ADEPS in Mons since 2019. She is also a member of the Club des Cardiologues du Sport (Sports Cardiologists Club).She joined the Interventional Cardiology, Prevention, and Rehabilitation team at Erasmus Hospital on December 1, 2023. She is currently further expanding her training in cardiovascular rehabilitation. Dr. Flores Vivian is originally from Mexico and is fluent in four languages. Book an appointement with Dr. Flores Vivian A team of specialists dedicated to your cardiovascular health PhysiciansProf. Philippe van de Borne – CardiologistDr. Gabriela Flores Vivian – University Hospital Practitioner, CardiologyDr. Caroline Carpentier – University Hospital Practitioner, Cardiology, Internal MedicineDr. Nina Leduc – CardiologistDr. Sonia Velez-Roa – CardiologistProf. Jean-Michel Hougardy – Chief Medical Officer of the H.U.B, Nephrology-Dialysis-Renal TransplantationProf. Marc Leeman – CardiologistFor sports cardiology and cardiovascular rehabilitation, we also collaborate with Dr. Axel Marlaire – Physical Medicine, Sports Medicine Consultation Book an appointment with one of our specialists Healthcare & Support TeamLucille Blaise – PhysiotherapistStéphanie Catelin – PhysiotherapistGwennaelle Demoulin – Social WorkerNathalie Egee – PsychologistAlexis Gillet – PhysiotherapistChantal Godefroid – PhysiotherapistMichel Lamotte – PhysiotherapistCorentin Scoubeau – PhysiotherapistJonathan Strapart – PhysiotherapistSophie Vanden Eynde – PsychologistElodie Van Lil – PhysiotherapistMarie-Eve Velghe – Dietitian  The departments we work with Cardiology Lien vers Cardiology Diabetology Lien vers Diabetology Nutrition Physiotherapy and Physical Medicine Lien vers Physiotherapy and Physical Medicine Psychology Lien vers Psychology Neurology Lien vers Neurology Pneumology Lien vers Pneumology Tabacology Internal Medicine Lien vers Internal Medicine Useful Resources and Links on Cardiovascular Prevention These resources offer valuable information on the prevention, diagnosis, and management of cardiovascular diseases in Belgium, in connection with the activities of the H.U.B Cardiovascular Prevention Clinic. PRESENTATION – 5 benefits of physical activity on cardiovascular health. PATIENT ASSOCIATION – Belgian Cardiological League (Ligue Cardiologique Belge) PATIENT ASSOCIATION – League of Healthcare Users (Ligue des Usagers de Soins de… WORKING GROUP – Belgian Hypertension Committee WORKING GROUP – Belgian Working Group on Preventive Cardiology (BWGPC) WORKING GROUP – French Society of Arterial Hypertension (Société Française d’Hy… WORKING GROUP – The Belgian Lipid Club / Belgian Atherosclerosis Society WORKING GROUP – Belgian Working Group on Heart Failure (BWGHF) WORKING GROUP – Belgian Working Group on Cardiovascular Nursing (BWGCVN) ARTICLE – Turn to patient associations (LUSS) WEBSITE – List of patient associations (Health Belgium) PODCAST – "Straight from the heart" (« Ça vient du cœur » - Belgian Cardiologic… ARTICLE – The heart and sports activities: The 10 golden rules VIDEO – Lifelong prevention: The red line at EAPC (in English) ARTICLE – Diet: A precious asset in stroke prevention FAQ on cardiovascular health 1. What are the main cardiovascular risk factors? Smoking, hypertension, high cholesterol, diabetes, being overweight, a sedentary lifestyle, stress, and family history are the main risk factors. 2. Is my current diet suitable for protecting my heart? A diet rich in vegetables, fruits, and fiber, and low in saturated fats is recommended. We evaluate your habits to offer personalized advice. 3. What tests are necessary to assess my cardiovascular risk? A blood test, blood pressure measurement, an electrocardiogram (ECG), an echocardiogram, or a stress test can be performed depending on your needs. 4. What is the best physical activity for my cardiovascular health? Endurance activities such as brisk walking, cycling, or swimming, practiced for 30 minutes a day, are ideal. 5. How can I lower my cholesterol without medication? Adopt a diet rich in fiber and healthy fats (omega-3s), increase physical activity, and limit saturated and trans fats. 6. Should I monitor my blood pressure every day? It depends on your situation. Regular, but not necessarily daily, monitoring may be sufficient unless medically advised otherwise. 7. What are the warning signs of a heart attack? Chest pain, shortness of breath, sweating, nausea, or feelings of pressure in the left arm require urgent medical attention. 8. Can sleep apnea affect my heart? Yes, it increases the risk of hypertension, arrhythmia, and other cardiovascular complications.   9. How can I stop smoking to reduce cardiovascular risks? Medical support, behavioral therapies, and nicotine substitutes significantly increase the chances of success. 10. Does my daily stress impact my cardiovascular health? Yes, chronic stress can raise blood pressure and worsen cardiovascular risks.

On Thursday 20 February 2025, the ‘Red Blood Cell’ group of the Belgian Haematology Society and the H.U.B. are organising the next Red Blood Cell Day. Discover the programme and the speakers.  Program & speakers This event will take place at the Jules Bordet Institute, Rue Meylemeersch 90, 1070 Anderlecht, in the Tagnon Auditorium, 1st FloorSession for healthcare professionals09h00Eosinophils and SCD : Bad couple ?S. Karimi (HUB - Brussels)09h30Sickle Cell NephropathyV. Labarque (KUL - Leuven)10h00Vaccination in SCD - What is a realistic approach ?M. Hoyoux (CHU Liège - Citadelle)10h30Coffee Break 10h50Immunological and Practical Aspects of Transfusion in HemoglobinopathiesV. Deneys (CUSL - UCL - Brussels)11h20Transfusional Optimization in Transfusion-Dependent ThalassemiaG. De Luna  (Henri Mondor -APHP - Paris)11h50HSCT in Hbpathies : New regimens versus new therapiesF. Bernaudin (CHIC - Paris)12h20Cerebrovascular workup in SCDB. Biemond (UMC - Amsterdam)13h00Lunch 14h00Diagnostic pitfalls and New Therapies in RBC EnzymopathiesF. Galacteros (Henri Mondor -APHP - Paris)14h30Clinical reesearch in remote region - Experience in DRCB. Mbiya (Centre Mashi - Mbujimayi)15h00Systemic racism vs Care : A sickle cell perspectiveM. Shema (UMF lasi)15h30Pain at Home - Evolution of pain after hospital dischargeL. Vinguetama-Périanagom (ULB - Brussels)16h00Alternatives to opioïd analgesiaC. Greco (Necker-Enfants Malades - APHP - Paris)16h30Coffee Break Session for patients16h45Non-opioid analgesicsS. Hatton (Necker-Enfants Malades - APHP - Paris)17h15NutritionV. Hannecart (HUB - Brussels) & K. Egberts DrepaCoach17h45Access to healthcare and the stay or return of sick peopleS. Jassogne & K. Vanhees - Medimmigrant asbl18h45End of the event  Inscription - Professionnels de santé Inscription - Patients En collaboration avec